Advertisement

Related Videos

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Opportunities to Optimize Cancer Policies Panel Discussion

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

Welcome and Introduction to Vi3C

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Advertisement

Advertisement




Jun
18
Today In Oncology
New ACSM Expert Consensus Statement: Exercise in Children and Adolescents With Cancer
Preclinical Research Shows Interferon May Attenuate Neutrophil Response to Cancer Immunotherapy
Low-Dose Tamoxifen in Noninvasive Breast Neoplasia
Relapsed or Refractory Multiple Myeloma Talquetamab Daratumumab
FDA Approves Capivasertib Plus Abiraterone and Prednisone for Metastatic Prostate Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo